Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...

Oligonucleotide-based therapeutics are transforming biopharmaceutical research, yet their structural complexity continues to test the limits of analytical technology. Precise fragmentation and ...

Researchers from Yunnan University, the Shanghai Astronomical Observatory (SHAO) of the Chinese Academy of Sciences, and the National Astronomical Observatory of Japan have unveiled new insights into ...

New research models how crosschain price gaps and capital friction are eroding efficiency as tokenized markets scale across blockchains. Fragmentation across blockchain networks is already imposing a ...

Therapeutic oligonucleotides (ONs) offer promising treatments for conditions beyond what traditional therapies can target. As a new class of molecules, they demand precise characterization in both ...

The Financial Industry Regulatory Authority (FINRA)’s Board of Governors has approved a major overhaul of its pattern day trading (PDT) rules, marking a critical shift in how active retail trading ...

Pattern made its debut on the Nasdaq after raising $300 million for the company and its investors in an IPO. The Utah-based company is one of the top sellers on Amazon's third-party marketplace. "No ...

Large intact forests and connected landscapes support biodiversity and ecosystem processes. Globally, more than half of the world’s forests became more fragmented between 2000 and 2020, according to a ...

SAN FRANCISCO – Spacedock, a Silicon Valley startup formerly known as Orbital Outpost X, announced plans Aug. 20 for a 2026 in-space demonstration of a universal connector for space systems. Working ...

Delivering cutting-edge peer-reviewed research on using nucleic acids and related compounds to alter gene expression for therapeutic purposes. A new article in the peer-reviewed journal Nucleic Acid ...